1.The Role of Membrane TNF-a in Murine Con A-LAK Cell Mediated MHC Non-restricted Tumoricidal Effect
Yali ZHAO ; Guangxia SHI ; Lianyin GUO
Chinese Journal of Cancer Biotherapy 1996;0(04):-
This essay investigated the in vitro tumoricidal activity of Con A primed murine LAK cells (Con A-LAK), discussed the role of mTNF-? in the killing effect. The results showed that Con A-LAK cells could kill NK sensitive YAC-1, TNF sensitive L929 and H-2 low/non expression HCa-F target cells; The cytotoxicitity of Con A-LAK cells was performed by direct contact, the non-secretary pathway mediated by interaction of surface ligands of effector cells and receptors of target cells play an important role; Con A-LAK cells expressed mTNF-?, which participated in the killing of TNF sensitive tumor cells and might be one of the important effector molecules in MHC non-restricted, antigen non-specific cvtotoxicitv.
2.Effect of sevoflurane on left ventricular function in patients undergoing coronary artery bypass grafting
Boxiang DU ; Hongwei SHI ; Yali GE
Chinese Journal of Anesthesiology 2009;29(11):1016-1019
Objective To evaluate the effect of sevoflurane on left ventricular function in patients undergoing elective coronary artery bypass grafting (CABG) .Methods Thirty-five ASA Ⅱ or Ⅲ patients of both sexes (30 males, 5 females) aged 53-75 yr weighing 46-100 kg undergoing CABG were enrolled in this study. Transesophageal echocardiography (TEE) probe was placed. The TEE variables including cardiac index (CI), left ventricular short axis shortening (FS), left ventricular ejection fraction (LVEF), low propagation velocity ( Vp), E wave velocity (E) , A wave velocity ( A) , systolic wave velocity ( S) , diastolic wave velocity ( D), AR wave velocity, E/A ratio and S/D ratio were recorded before inhalation of sevoflurane (T_1 ) , and 5 min (T_2) and 15 rain ( T_3) after inhalation of sevoflurane after splitting of sternum, and before inhalation of sevoflurane (T_4 ), 5 min (T_5) and 15 min (T_6) after inhalation of sevoflurane after the closure of sternum. The end-tidal concentration of sevoflurane corresponded to 1 MAC. Anesthesia was induced with midazolam 0.05 nig/kg, sufentanil 0.5μg/kg and rocuronium 0.9 mg/kg and maintained with infusion of propofol at 4-6 mg·kg~(-1) ·h~(-1), remifentanil at 0.2-0.4μgkg~(-1)·h~(-1) and atracurium at 0.5 mg·kg~(-1)·h~(-1). The patients were mechanically ventilated after tracheal intubation (V_T 8 ml/kg, RR 12 bpm, I:E 1:2, FiO_2 70%-80% ) .Results (1) MAP and CI were significantly decreased at 5 and 15 min after sevoflurane inhalation. LVEF and FS were also decreased. (2) There was no significant change in diastolic function indexes after sevoflurane inhalation including E and A wave velocity, systolic wave velocity, diastolic wave velocity, E/A ratio and S/D ratio. (3) Cardiac function improved after CABG. CI, LVEF and FS were significantly increased after CABG as compared with preoperative values. Conclusion In patients undergoing elective CABG, sevoflurane (the end-tidal concentration corresponding to 1 MAC) can depress left ventricular systolic function but does not affect left ventricular diastolic function.
3.Expression of GnRH and GnRH-R in various endometrial tissue and its significance
Yiping ZHANG ; Yali LI ; Changxu SHI
Medical Journal of Chinese People's Liberation Army 1983;0(05):-
Objective To detect the protein expression of gonadotropin-releasing hormone (GnRH) and its receptor (GnRH-R) in various endometrial tissues, and to investigate its significance. Methods Immunohistochemistry was employed to analyse the protein expression and localization of GnRH and GnRH-R from endometriosis(EMS), endometrial hyperplasia, endometrial carcinoma and control group. Results GnRH and GnRH-R are expressed at the protein level in all eutopic endometrium, in 50% ectopic endometrium and 92.3% endometrial hyperplasia, while the expressional rate in endometrial carcinoma are 58.8% and 82.4%, respectively. The majority of GnRH and GnRH-R existed in the plasma of glandular epithelium cells and some stroma cells. Conclusions There exists GnRH and its receptor proteins in endometrial tissues, and their abundant expression in endometriosis, endometrial hyperplasia and in endometrial carcinoma may imply that they could be used in clinical diagnosis and treatment.
4.Analysis of knowledge-attitude-practice about rational drug use among urban and rural tumor patients in Shanxi province
Yali JIA ; Weigang WANG ; Suhua HAO ; Yingtao SHI
Cancer Research and Clinic 2016;28(10):696-698,720
Objective To study the difference on knowledge-attitude-practice about rational drug use in tumor patients between urban and rural in Shanxi province, and to provide evidence for further development on health education of rational drug use. Methods A questionnaire investigation was conducted among tumor inpatients in Shanxi Cancer Hospital from May 22 in 2014 to May 30 in 2014. Results A total of 990 tumor patients were involved, including 499 urban patients accounting for 50.4 % and 491 rural patients accounting for 49.6 %. The tumor patients′awareness rates of 'the purchase of antibiotics needs a prescription' in urban and rural areas were the highest, 74.9 % (374/499) and 67.0 % (329/491), respectively, and the awareness rates of 'the meaning of OTC on the medicine package' were the lowest, 22.0 % (110/499) and 18.1 % (89/491), respectively. 96.2%(480/499) urban and 92.7%(455/491) rural tumor patients had developed a correct attitude towards 'irrational drug use will affect health and even life-threatening' which ranked the highest, and the rates of correct attitude towards 'adverse drug reaction is the medical accident' were the lowest, 55.5 %(277/499) and 48.1 % (236/491), respectively. The correct behavior rates of 'read the drug instructions' in urban and rural tumor patients were the highest, 97.8% (488/499) and 95.1 % (467/491), respectively, and the correct behavior rates of 'the expired drug recovery to nearby regular pharmacy' were the lowest, 9.2 %(46/499) and 7.5 % (37/491), respectively. Conclusions The knowledge-attitude-practice about rational drug among urban and rural tumor patients in Shanxi province is not optimistic. It should be provided that individual health education in daily work in order to promote rational drug use, prolong survival time and improve the quality of life for tumor patients.
5.Clinical Observation of Leflunomide Combined with Prednison in the Treatment of Membranous Nephropathy
Yali MA ; Fang CHEN ; Jun SHI ; Baoping CHEN
China Pharmacy 2016;27(23):3224-3225,3226
OBJECTIVE:To explore the efficacy and safety of leflunomide combined with prednison in the treatment of membra-nous nephropathy. METHODS:43 patients with primary membranous nephropathy were randomly divided into control group(21 cas-es) and test group (22 cases). Control group given cyclophosphamide interrupted shocks combined with prednison,test group re-ceived leflunomide combined with prednison,the treatment course for both groups was 12 months. 6 months after the treatment,clini-cal efficacy,changes in renal function and serum lipids indexes before and after treatment,and the incidence of adverse reactions in 2 groups were observed. RESULTS:The total effective rate in test group was 63.64%,which was significantly higher than control group (23.81%),the difference was statistically significant (P<0.05). After treatment,urine protein in 2 groups significantly de-creased,plasma albumin significantly increased,serum creatinine,serum cholesterol,triglycerides and low-density lipoprotein signifi-cantly decreased,the differences were statistically significant(P<0.05);and the changes of above-mentioned indexes(except blood cholesterol)in test group were more significantly than control group,the differences were statistically significant(P<0.05). The inci-dence of adverse reactions in test group was 9.09%,control group was 9.52%,there was no significant difference between 2 groups (P>0.05). CONCLUSIONS:Compared with cyclophosphamide interrupted shocks combined with prednison,the efficacy of lefluno-mide combined with prednison in the treatment of membranous nephropathy is more definite,and the improvement of renal function and serum lipids indexes is more obvious.
6.A Randomized and Controlled Study of rhGM-CSF on Leucopenia Induced by Chemotherapy on Cancer Patients
Guanghai DAI ; Tiangzhang SHI ; Jianjin HUANG ; Yali LIU
Chinese Journal of Cancer Biotherapy 1995;0(02):-
Objective: To evaluate the efficacy and tolerability of rhGM-CSF in prevention of neutropenia caused by chemothera- py of cancer patients. Methods: A muticenter, randomized,match and crossover clinical study was conducted. 64 enrolled patients were randomized into AB and BA groups and each patient received two cycles of combination chemotherapy.Results:59 patients were evaluted for clinical efficacy.rhGM-CSF significantly increased the number of WBC and ANC at the stage of nadir. The period when the patients, rhGM-CSF also resulted in a hastening recovery from leucopenia and neutropenia.Conclusion: The administraton of rhTM-CSF ensures the implement of sheduled combination chemotherapy. The main side effects such as fever, osteomyalgia,skin rash were generally tolerable.
7.Study of SIVP Improving Detectable Rate of Hepatocarcinoma in Cirrhosis
Yali GE ; Minwen ZHENG ; Yi HUAN ; Mingguo SHI
Journal of Practical Radiology 2001;0(06):-
Objective To study the clinical applications of SIVP detecting hepatocarcinoma in cirrhosis.Methods 40 cases of cirrhosis combined with hepatocarcinoma diagnosed by operation and pathology were collected.Control group were scaned with conventional technique,experimental group were scaned with SIVP.Results Only 5 cases catched the optimal scan timing in control group,the accuracy of diagnosis in hepatocarcinoma was 70%;All the cases found the optimal scan timing in experimental group,the detectable rate of hepatocarcinoma was 95%.Conclusion SIVP can find out the optimal timing,which greatly improved accuracy of diagnosing hepatocarcinoma in cirrhosis.
8.CT Diagnosis of Adrenal Myelolipoma
Minwen ZHENG ; Yali GE ; Yi HUAN ; Mingguo SHI ; Jinsong ZHANG
Journal of Practical Radiology 1992;0(11):-
Objective To analysis the CT features and differential points of adrenal myelolipoma.Methods The CT and clinical information of 9 adrenal myelolipomas were collected.Results CT diagnosed 8 cases of adrenal myelolipoma except 1 case misdiagnosing as adenoma.All mass measuring 2.8~10.5 cm in diameter with clear edge,low attenuation value of fat and irregular linear shadow of soft tissure might be seen in mass.Conclusion CT is the best examination of diagnosing,which could show the position,component of the mass and organs around it.
9.CT Diagnosis of Adrenocortical Carcinoma
Minwen ZHENG ; Yali GE ; Yi HUAN ; Mingguo SHI ; Jinsong ZHANG
Journal of Practical Radiology 1996;0(04):-
Objective To analysis diagnostic CT findings of adrenocortical carcinoma.Methods To collect 13 adrenocortical carcinomas verified by operation and pathology from 1990 to 1999.Results 8 cases were functional tumor and 5 were non-function mass.The diameter of 10 cases was more than 5 centimeters.The density of carcinoma was not equality and necrosis was often be found.The edge of 6 cases were clear and 7 were not clear,3 cases had local invade and metastasis.Conclusion CT can diagnose most of functional adrenocortical carcinoma with clinic syndrome but can not differentiate non-function adrenocortical carcinoma from pheochromocytoma.
10.CT Findings of Rare Adrenal Interstitial Tissue Tumors
Minwen ZHENG ; Yali GE ; Yi HUAN ; Mingguo SHI ; Jinsong ZHANG
Journal of Practical Radiology 2001;0(06):-
Objective To analysis the CT features in 7cases of rare adrenal interstitial tissue tumors.Methods 7 cases of rare adrenal interstitial tissue tumors were verified with operation and histology.2 cases were cyst and 2 were lipoma,neurofibroma,neurilemoma and mesenchymoma was 1 case,respctively.Results Adrenal cyst and lipoma appered the density of water and fat.neurofibroma and neuriemoma were slightly low density mass,without enhancement.There were cystic lesion in neurilemoma.Mesenchymoma had slight or moderate enhancement.Conclusion It is difficult or impossible to distinguish nuerofibroma,neurilemoma or mesenchymoma from non-function adenoma or pheochromocytoma except adrenal cyst and lipoma.